Literature DB >> 9225292

Radioligand binding and photoaffinity labelling studies show a direct interaction of phenothiazines at 5-HT3 receptors.

S C Lummis1, J Baker.   

Abstract

The effects of a range of phenothiazines were examined on 5-hydroxytryptamine3 (5-HT3) receptors in membranes from NIE-115 neuroblastoma cells using radioligand binding. Chlorpromazine, fluphenazine, perphenazine, trifluoperazine and prochlorperazine inhibited specific binding of both the 5-HT3 receptor antagonist [3H]GR65630 and agonist [3H]meta-chlorophenylbiguanide (mCPBG), with Ki values ranging from 0.4 to 3.9 microM. The mode of action of chlorpromazine was further examined using photoaffinity labelling in the presence and absence of 5-HT. Saturation radioligand binding data with both [3H]GR65630 and [3H]mCPBG showed that photoaffinity labelling with chlorpromazine (1 microM) caused a decrease in the maximum number of binding sites observed (35% and 28% for agonist and antagonist, respectively). This decrease was not observed when the membranes were incubated in the presence of 5-HT. The results demonstrate a direct interaction of a range of phenothiazines at the 5-HT3 receptor binding site.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9225292     DOI: 10.1016/s0028-3908(97)00054-3

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  6 in total

1.  Allosteric binding site in a Cys-loop receptor ligand-binding domain unveiled in the crystal structure of ELIC in complex with chlorpromazine.

Authors:  Mieke Nys; Eveline Wijckmans; Ana Farinha; Özge Yoluk; Magnus Andersson; Marijke Brams; Radovan Spurny; Steve Peigneur; Jan Tytgat; Erik Lindahl; Chris Ulens
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-10       Impact factor: 11.205

2.  Frequency-dependent, cell type-divergent signaling in the hippocamposeptal projection.

Authors:  Joanna Mattis; Julia Brill; Suzanne Evans; Talia N Lerner; Thomas J Davidson; Minsuk Hyun; Charu Ramakrishnan; Karl Deisseroth; John R Huguenard
Journal:  J Neurosci       Date:  2014-08-27       Impact factor: 6.167

Review 3.  The 5-HT3 receptor as a therapeutic target.

Authors:  Andrew J Thompson; Sarah C R Lummis
Journal:  Expert Opin Ther Targets       Date:  2007-04       Impact factor: 6.902

4.  A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle.

Authors:  Karuppiah Chockalingam; Rudo L Simeon; Charles M Rice; Zhilei Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-08       Impact factor: 11.205

Review 5.  5-HT3 receptors.

Authors:  A J Thompson; S C R Lummis
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

6.  Antiviral drugs against hepatitis C virus.

Authors:  Sidra Rehman; Usman A Ashfaq; Tariq Javed
Journal:  Genet Vaccines Ther       Date:  2011-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.